Brief: AC Immune Q3 EPS CHF -0.18
03/11/2023 11:07
Nov 3 (Reuters) - AC Immune Q3 net income CHF -15.143 million. * Q3 operating expenses CHF -15.466 million * Q3 operating income CHF -15.466 million * Q3 pretax profit CHF -15.14 million * Q3 EPS CHF -0.18
Recent news on AC Immune AG
See all newsAC Immune rises after Parkinson's drug shows promise in mid-stage trial
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health